iSOFT Group Limited (ISF) SWOT Profile---Aarkstore Enterprise Market Research Aggregation

SummaryJan 11, 2010: Universal Biosensors Announces
Universal Biosensors, Inc. (UBI) SWOT Profile is aBoard Changes
comprehensive business, functional and strategicDec 10, 2009: Universal Biosensors Wins
analysis of Universal Biosensors, Inc.. The profileCommercial Order For Blood Glucose Strips
delves into the operations of the company to
present an in-depth analysis of the variousScope
aspects related to its business. It analyzes the- Examines key information about company for
company's business structure, operations, majorbusiness intelligence.
products and services, prospects, locations and- The company's core strengths and weaknesses
subsidiaries, executive biographies and keyand areas of development or decline are analyzed
competitors. The hallmark of the profile is theand presented objectively. Business, strategic and
detailed strategic analysis of the company. Thisoperational aspects are taken into account.
highlights and presents an unbiased view of its- Opportunities available to the company are sized
key strengths and weaknesses and the potentialup and its growth potential assessed. Competitive
opportunities and threats. The profile helps youand/or technological threats are highlighted.
formulate strategies that augment your business- The profile contains valuable and critical company
by understanding your partners, customers andinformation – business structure and
competitors better.operations, the company history, major products
Universal Biosensors, Inc. (Universal Biosensors) isand services, prospects, key competitors, key
a medical diagnostics company that is engaged inemployees, executive biographies, important
the research, development, manufacture andlocations and subsidiaries.
commercialization of in vitro diagnostic tests for- The profile provides detailed financial ratios for
point of care market. The diagnostic tests consistthe past five years as well as interim ratios for
of a novel disposable test strip and a reusablethe last five interim periods for major public
meter. It develops point of care blood tests likecompanies.
C-reactive protein test, D-dimer test and- Financial ratios presented for major public
Prothrombin time test.companies include revenue trends, profitability,
Key Recent Developmentsgrowth, margins and returns, liquidity and leverage,
Jan 28, 2010: LifeScan Launches One Touch Veriofinancial position and efficiency ratios.
In Netherlands